InsiderTrades.com logo
The Gold Grab of the Century
From Colonial Metals   |   Ad
When central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.
That's why we have released our Free Precious Metals Investment Guide.
Jason A. Clemens net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

Jason Clemens Biography and Net Worth

CFO of AdaptHealth
Jason Clemens joined AdaptHealth from MEDNAX, Inc. (“MEDNAX”) (NYSE: MD), a national provider of health solutions to hospitals, health systems, and healthcare facilities, where he served as Senior Vice President and Operations Chief Financial Officer. Over a nine-year career at MEDNAX, Mr. Clemens held positions of increasing responsibility in operations management and finance. Prior to joining MEDNAX, Mr. Clemens gained experience with the United States Army, supporting the Republic of Korea Army in Wonju, South Korea. He later served in progressive roles within operations management and finance at Accenture, Lennar, and Ryder. Mr. Clemens holds a B.S. in Industrial Engineering from Lehigh University, and an M.S. in Finance and M.B.A. from the Indiana University Kelley School of Business. He is also a Chartered Financial Analyst (CFA) and a Certified Six Sigma Blackbelt.

What is Jason A. Clemens' net worth?

The estimated net worth of Jason A. Clemens is at least $1.86 million as of August 10th, 2023. Mr. Clemens owns 194,120 shares of AdaptHealth stock worth more than $1,859,670 as of April 26th. This net worth evaluation does not reflect any other assets that Mr. Clemens may own. Additionally, Mr. Clemens receives a salary of $870,200.00 as CFO at AdaptHealth. Learn More about Jason A. Clemens' net worth.

How old is Jason A. Clemens?

Mr. Clemens is currently 45 years old. There are 5 older executives and no younger executives at AdaptHealth. The oldest executive at AdaptHealth is Mr. Richard Alan Barasch, Chairman of the Board & Interim CEO, who is 70 years old. Learn More on Jason A. Clemens' age.

What is Jason A. Clemens' salary?

As the CFO of AdaptHealth Corp., Mr. Clemens earns $870,200.00 per year. The highest earning executive at AdaptHealth is Mr. Joshua Parnes, President & Director, who commands a salary of $1,040,000.00 per year. Learn More on Jason A. Clemens' salary.

How do I contact Jason A. Clemens?

The corporate mailing address for Mr. Clemens and other AdaptHealth executives is 220 West Germantown Pike Suite 250, Plymouth Meeting PA, 19462. AdaptHealth can also be reached via phone at (610) 424-4515 and via email at [email protected]. Learn More on Jason A. Clemens' contact information.

Has Jason A. Clemens been buying or selling shares of AdaptHealth?

Jason A. Clemens has not been actively trading shares of AdaptHealth in the last ninety days. Most recently, on Thursday, August 10th, Jason A. Clemens bought 720 shares of AdaptHealth stock. The stock was acquired at an average cost of $14.10 per share, with a total value of $10,152.00. Following the completion of the transaction, the chief financial officer now directly owns 194,120 shares of the company's stock, valued at $2,737,092. Learn More on Jason A. Clemens' trading history.

Who are AdaptHealth's active insiders?

AdaptHealth's insider roster includes Jason Clemens (CFO), Stephen Griggs (CEO), Ronald Mcdaniel (Director), Frank Mullen (CAO), Alan Quasha (Director), Shaw Rietkerk (COO), and Dale Wolf (Director). Learn More on AdaptHealth's active insiders.

Are insiders buying or selling shares of AdaptHealth?

In the last year, AdaptHealth insiders bought shares 1 times. They purchased a total of 720 shares worth more than $10,152.00. In the last year, insiders at the sold shares 5 times. They sold a total of 527,501 shares worth more than $6,709,619.15. The most recent insider tranaction occured on March, 11th when Major Shareholder James E Flynn sold 182,607 shares worth more than $2,012,329.14. Insiders at AdaptHealth own 13.6% of the company. Learn More about insider trades at AdaptHealth.

Information on this page was last updated on 3/11/2024.

Jason A. Clemens Insider Trading History at AdaptHealth

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/10/2023Buy720$14.10$10,152.00194,120View SEC Filing Icon  
12/1/2021Buy1,300$19.77$25,701.00View SEC Filing Icon  
See Full Table

Jason A. Clemens Buying and Selling Activity at AdaptHealth

This chart shows Jason A Clemens's buying and selling at AdaptHealth by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

AdaptHealth Company Overview

AdaptHealth logo
AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also offers wheelchairs, hospital beds, oxygen concentrators, CPAP masks and related supplies, wound care supplies, diabetes management supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.
Read More

Today's Range

Now: $9.58
Low: $9.51
High: $9.80

50 Day Range

MA: $10.00
Low: $7.10
High: $11.51

2 Week Range

Now: $9.58
Low: $6.37
High: $15.37

Volume

469,020 shs

Average Volume

1,083,053 shs

Market Capitalization

$1.27 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.02
The Gold Grab of the Century
From Colonial Metals   |   Ad
When central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.
That's why we have released our Free Precious Metals Investment Guide.